cell line development, antibody production, clonal screening

An established, proven solution

Systems based on ClonePix technology are now used in over 100 laboratories around the world to increase workflow productivity, leaving more time to better characterize target proteins and run new projects.

Companies such as GSK, Merck, Wyeth, Genentech, Centocor, MedImmune, UCB and Genmab have implemented ClonePix systems and data are cited increasingly in scientific conferences. 

Automatically screening more clones in less time than conventional techniques, selecting cells with optimal expression levels, and picking colonies with accuracy enables scientists to:
  • Increase probability of finding optimal producers
  • Cut cell line/antibody development times – avoid limiting dilution
  • Reject poor performers at an early stage based on expression levels in situ

Introducing ClonePix 2

ClonePix™ 2 is the next generation system built on ClonePix technology and chemistries.
  • Select cells with optimal expression levels
    • Software enhancements improve ranking consistency
  • Pick colonies with accuracy and confidence
    • Robotics redesign reduces risk of colony disturbance
  • Improved workflow efficiency
    • Fewer plate handling steps
clonal screening

View the ClonePix workflow

Get ADOBE FLASH PLAYER

No FLASH PLAYER found!

Please download ADOBE® FLASH® PLAYER from adobe.com
“We have implemented ClonePix to increase our fusion productivity by approximately 50%, while decreasing our time from fusion to stable clone by 50%”
Dr. Robin Barbour,
Elan Pharmaceuticals
“ClonePix has great advantages in selecting optimal producer cell lines and shortening timelines for early stage cell line development”
Dr. Jianguo Yang, Group Leader in Cell Line Development, MedImmune
“ClonePix will greatly enhance our ability to isolate and identify natural and recombinant antibody production in cells early in the selection process...”
Jeff Hutchins - Inhibitex
Brochures
Preview
ClonePix™ 2
Screening and selection of mammalian clones
* Please log in to access this document
Preview
Accelerate Cell Line Development
ClonePix with CloneSelect Imager
* Please log in to access this document
Recorded Webinars

Using high throughput automated selection to increase discovery of rare, high producing mammalian cell lines

Dr Dharshanan presents how the use of ClonePix has increased the probability of finding rare high producing clones at Inno Biologics.
Listen now >

Optimal selection of monoclonal cell lines producing high amounts of biopharmaceutical human IgGs

Dr Gerritsen, Technology Expert, explains how Genmab have optimized and integrated emerging technologies to achieve an optimal, state-of-the-art process for generation of CHO cell lines expressing therapeutic IgGs.
Listen now >
Contact Molecular Devices
Request more information
Contact us